Akheel Mohammad, Senthilmurugan M, Sherlin Herald J, Jain Amit, Chahwala Qutubuddin, Wadhwania Ashmi
Ph.D. Scholar, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu India.
Dept of Oral Oncology, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu India.
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):6001-6006. doi: 10.1007/s12070-021-02629-2. Epub 2021 May 29.
Oral squamous cell carcinoma (SCC) is one among the most frequent cancers across the globe. The postoperative overall survival (OS) has not improved over years much despite of advanced surgical techniques and various anticancer drugs. A better and good understanding of molecular mechanisms and identification of potential oncogenes in OSCC may provide new therapeutic decisions such as target therapy in management of these cancer patients. To find whether there is any association between surgical margins and pathological staging with epidermal growth factor receptor expression affecting the prognosis in oral squamous cell carcinomas. A prospective cohort study was performed in 25 patients with biopsy proven oral squamous cell carcinoma who presented to our hospital from July 2017 to June 2019. The data collected from their report were pTNM staging, surgical margins (anterior, posterior, superior and inferior) and scoring of EGFR expression. Surgical margins with EGFR expression was found to have -value of 0.023 and pTNM staging with EGFR expression was found to have -value of 0.051 which were statistically significant. This study concludes that there is strong association of EGFR expression with pTNM and surgical margins which may influence the prognosis of the patient. This study helps us to understand the need of adding EGFR targets like cetuximab along with radiation instead of conventional cisplatin therapy.
口腔鳞状细胞癌(SCC)是全球最常见的癌症之一。尽管有先进的手术技术和各种抗癌药物,但多年来术后总生存率(OS)并没有太大改善。更好地理解分子机制并识别口腔鳞状细胞癌中的潜在致癌基因,可能会为这些癌症患者的管理提供新的治疗决策,如靶向治疗。以探究手术切缘和病理分期与表皮生长因子受体表达之间是否存在关联,进而影响口腔鳞状细胞癌的预后。对2017年7月至2019年6月期间我院收治的25例经活检证实为口腔鳞状细胞癌的患者进行了一项前瞻性队列研究。从他们的报告中收集的数据包括pTNM分期、手术切缘(前、后、上、下)和表皮生长因子受体表达评分。发现手术切缘与表皮生长因子受体表达的P值为0.023,pTNM分期与表皮生长因子受体表达的P值为0.051,具有统计学意义。本研究得出结论,表皮生长因子受体表达与pTNM和手术切缘密切相关,可能影响患者的预后。本研究有助于我们理解在放疗的同时添加西妥昔单抗等表皮生长因子受体靶点而非传统顺铂治疗的必要性。